Timothy Schmid Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 3 days, 18 hours ago

Timothy Schmid has an estimated net worth of at least $24.9 million*, as of Sept. 30, 2026. They own 36,517 shares of JNJ stock. They have sold 57,945 shares of JNJ stock since 2021, for an estimated $15.1 million.

Timothy Schmid $JNJ SEC Form 4 Insider Trading

Timothy Schmid has filed a total of 6 insider trades in $JNJ since 2021. Their most recent trade was a sale of 11,070 shares, made on Sep 02, 2026. Their largest trade was a sale of 22,527 shares, made on Sep 02, 2026. We estimate that they now own 36,517 shares of $JNJ, worth an estimated $9.8 million.

Insider Trading at $JNJ

There have been a total of 384 insider trades reported at $JNJ since 2021, with 2,250 shares purchased and 1.5 million shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 22,527 shares reported by Timothy Schmid (EVP, WW Chair, MedTech), made on Sep 02, 2026.

History of Insider Stock Trades by Timothy Schmid

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
JNJ	Sale	11,070	Sep 02, 2026	Sept. 4, 2026, 9:08 a.m.
JNJ	Sale	22,527	Sep 02, 2026	Sept. 4, 2026, 9:08 a.m.
JNJ	Sale	1,322	Feb 20, 2026	Feb. 23, 2026, 6:20 p.m.
JNJ	Sale	13,625	Feb 18, 2026	Feb. 18, 2026, 10:11 p.m.
JNJ	Sale	8,998	Feb 18, 2026	Feb. 18, 2026, 10:11 p.m.
JNJ	Sale	403	Feb 18, 2025	Feb. 18, 2025, 10:33 p.m.

$JNJ Executives and Stock Owners with Insider Trades

Peter Fasolo, Exec VP, Chief HR Officer
Thibaut Mongon, Exec VP, WW Chair, Consumer
William Hait, See Remarks
Joseph J Wolk, Exec VP, CFO
Joaquin Duato, CEO and Chairman of the Board
Timothy Schmid, EVP, WW Chair, MedTech
Kathryn E Wengel, EVP, Chief GSC Officer
John C Reed, EVP, Innovative Medicine, R&D
Robert J Decker, Controller, CAO
Robert J Decker, VP Corporate Controller
James D. Swanson, EVP, CIO
Vanessa Broadhurst, EVP, Global Corp Affairs
Jennifer L Taubert, EVP, WWC. Innovative Medicine
Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals
Elizabeth Forminard, EVP, Chief Legal Officer
Kathryn E Wengel, EVP, Chief TO and Risk Officer
Ashley Mcevoy, EVP, WW Chair, MedTech
James D. Swanson, See Remarks

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.